Medplus Health Services Board of Directors

Get the latest insights into the leadership at Medplus Health Services. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Gangadi Madhukar Reddy Chairman & M.D & CEO
Dr. Cherukupalli Bhaskar Reddy Whole Time Director & COO
Mr. Anish Kumar Saraf Non Executive Director
Mr. Madhavan Ganesan Ind. Non-Executive Director
Mr. Murali Sivaraman Ind. Non-Executive Director
Ms. Aparna Surabhi Addnl.Non Exe.Independent Director

Medplus Health Services Share price

MEDPLUS

844

16.20 (1.96%)
NSE
BSE
Last updated on 29 Aug, 2025 | 15:29 IST
BUYSELL
Today's High

845.00

Today's Low

825.85

52 Week Low

616.00

52 Week High

1045.30

The current prices are delayed, login to your account for live prices

Medplus Health Services FAQs

The board at Medplus Health Services consists of experienced professionals, including Mr. Gangadi Madhukar Reddy , Dr. Cherukupalli Bhaskar Reddy , and others, overseeing the company’s strategic and corporate governance.

Directors at Medplus Health Services are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Gangadi Madhukar Reddy is the current chairman at Medplus Health Services.

Executive directors at Medplus Health Services are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Medplus Health Services adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Medplus Health Services, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.